Eventide Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-15,000
| Closed | -$1.79M | – | 152 |
|
|
2018
Q3 | $1.79M | Hold |
15,000
| – | – | 0.07% | 120 |
|
|
2018
Q2 | $1.53M | Hold |
15,000
| – | – | 0.06% | 119 |
|
|
2018
Q1 | $1.95M | Hold |
15,000
| – | – | 0.09% | 113 |
|
|
2017
Q4 | $1.46M | Hold |
15,000
| – | – | 0.08% | 116 |
|
|
2017
Q3 | $2.21M | Hold |
15,000
| – | – | 0.13% | 101 |
|
|
2017
Q2 | $2.41M | Hold |
15,000
| – | – | 0.15% | 92 |
|
|
2017
Q1 | $2.39M | Hold |
15,000
| – | – | 0.16% | 91 |
|
|
2016
Q4 | $1.82M | Hold |
15,000
| – | – | 0.12% | 96 |
|
|
2016
Q3 | $2.08M | Hold |
15,000
| – | – | 0.13% | 98 |
|
|
2016
Q2 | $2.72M | Buy |
+15,000
| New | +$2.72M | 0.17% | 90 |
|